Drug Profile
S 364735
Alternative Names: GSK 364735; S-364735Latest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Shionogi - GlaxoSmithKline (JV)
- Class Antiretrovirals
- Mechanism of Action HIV integrase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued HIV infections
Most Recent Events
- 30 Jul 2007 Discontinued - Phase-II for HIV infections treatment in USA (PO)
- 12 Mar 2007 Clinical data presented at the 14th Conference on Retroviruses and Opportunistic Infections (CROI-2007) added to the adverse events and pharmacokinetics section
- 31 Oct 2006 Phase-II clinical trials in HIV infections treatment in USA (PO)